As of mid-June 2006, the Food and Drug Administration (FDA) had completed 34 inspections of reproductive establishments as part of its enforcement of 21 CFR Part 1271, Subpart F, which became effective May 25, 2005. Sperm banks accounted for less than 20 percent of the inspections. Of the 34 inspections, only five establishments received Form 483 with a listing of observations from the investigator.

View the full newsletter in PDF format.